StockData
MaxCyte, Inc. logo

MaxCyte, Inc. (MXCT) income statement

MXCTNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 9/3065% below fair value
$1.25+0.08 (+6.84%)

Close on Nov 18, 2026Market cap $129.01MP/E –Yield –

See a number that looks wrong?